Cigna expands the role of two top execs

2024-01-17
高管变更
Cigna expands the role of two top execs
Preview
来源: FierceHealthcare
Evanko has worked at Cigna since 1998 and has held multiple leadership roles across the company, including heading its government business.
Two top leaders at Cigna will be taking on expanded roles with the company.
Chief Financial Officer Brian Evanko will maintain that title as well as take on the mantle of president and CEO of Cigna Healthcare, the company's insurance business. Eric Palmer, who currently leads its Evernorth arm as CEO, will also step into the role of executive vice president for enterprise strategy at the Cigna Group.
Cigna CEO David Cordani said that elevating Evanko and Palmer will help the company push toward its growth and strategic goals.
"With them at the helm of our two growth platforms, alongside their seasoned leadership teams, we believe we are well positioned to deliver on our strategy with clarity and purpose," Cordani said in a press release.
Evanko has worked at Cigna since 1998 and has held multiple leadership roles across the company, including heading its government business.
Palmer has spent 26 years at the company across a wide variety of roles, and since he took the helm of Evernorth in 2021, the business has continued to grow.
Alongside unveiling expanded roles for Evanko and Palmer, Cigna announced that Ann Dennison will join the company as deputy chief financial officer. Dennison previously served as the chief financial officer for Nasdaq.
In addition, the current president of Cigna's U.S. commercial business, Mike Triplett, plans to retire by the end of 2024. Bryan Holgerson, who has spent 22 years on the Cigna team, will succeed Triplett.
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
适应症
-
靶点
-
药物
-
来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。